Kenvue
Price: 18.05Company and Business Model
Kenvue (KVUE.US) operates in the consumer staples sector, focusing on personal care and hygiene products. Its core offerings include over-the-counter medications, skincare, and household cleaning products. Major business segments encompass health and wellness, beauty, and home care, with primary revenue sources derived from product sales in retail and e-commerce channels.
Investment Profile
The investment profile of Kenvue is more aligned with dividend investors due to its notable dividend yield of 6.0%. The stock exhibits moderate growth potential, making it suitable for those seeking a balance between income and capital appreciation. Its relatively stable performance and low volatility suggest a lower risk profile, appealing to investors with a medium to long-term horizon.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 0.85 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- 3.4% ↑
- EPS surprise
- 18.5% better than expected
- 20d volatility
- 1.6% stable
- Dividend yield
- 4.6% high last ex-date: 2026-05-13
Track in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-10 00:48 | Hold | Buy | Strong fundamentals and solid dividend yield support growth. |
| 2026-05-30 02:43 | Buy | Hold | Stable dividend, but weak momentum and high risk. |
| 2026-05-22 02:50 | Hold | Buy | Stable dividend, moderate growth, mixed momentum signals. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-04-14 12:53 | Barclays | Target Lowered | 19 → 18 | 17.385 |
| 2026-02-18 12:42 | UBS | Target Raised | 17 → 19 | 18.41 |
| 2026-02-18 12:10 | Canaccord Genuity | Target Raised | 17 → 18 | 18.41 |
Nothing yet